Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 2,235 shares at $0.39 ($1K) on 2023-07-13, disclosed to the SEC on 2023-07-17.
Scheduled sale ($1k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.39 | 1,329 | $518 | 49.2% |
| 2 | $0.59 | 906 | $535 | 50.8% |
| Total | $0.47 avg | 2,235 | $1K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |